Encyclopedia of Biopharmaceutical Statistics 2nd Ed. - (Malestrom) - 2048BT - 全球最新最全bt种子资源在线搜索库，实时索引全球磁力链接资源

BT种子名称

分享给好友

BT种子基本信息

种子哈希：f803b1eba1bb0ea77e4b8efac10206ecead270cf
文档大小：65.0 MB
文档个数：197个文档
下载次数：743次
下载速度：极快
收录时间：2020-04-14
最近下载：2024-09-22
DMCA/屏蔽：DMCA/屏蔽

下载磁力链接

magnet:?xt=urn:btih:F803B1EBA1BB0EA77E4B8EFAC10206ECEAD270CF
复制磁力链接到utorrent、Bitcomet、迅雷、115、百度网盘、PIKPAK等下载工具进行下载。

下载BT种子

磁力链接种子下载迅雷下载二维码含羞草 51品茶 91视频逼哩逼哩欲漫涩草榴社区抖阴破解版成人快手暗网禁区缅北禁地 TikTok成人版暗网解密

Encyclopedia of Biopharmaceutical Statistics 2nd Ed. - (Malestrom)的二维码

文档列表

Ac-As/Analysis of Variance.pdf 1.7 MB
Ka-Mu/Microarray Gene Expression.pdf 1.2 MB
Ba-Ca to Ce-Cu/Biopharmaceutics.pdf 1.1 MB
No-Pr/Pharmacoeconomics.pdf 1.0 MB
Qt-St to Su-Zs/Validation of Quantitative and Qualitative Assays.pdf 1.0 MB
No-Pr/Process Validation.pdf 1.0 MB
Qt-St to Su-Zs/Response Surface Methodology.pdf 1.0 MB
Da-Fa to Fo-In/Extra Variation Models.pdf 947.2 kB
Ka-Mu/Logistic Regression.pdf 897.7 kB
Qt-St to Su-Zs/Statistical Process Control.pdf 818.4 kB
Ba-Ca to Ce-Cu/Clinical Data Management.pdf 803.7 kB
Da-Fa to Fo-In/Factorial Designs.pdf 756.1 kB
Qt-St to Su-Zs/Vaccine Clinical Trials.pdf 727.0 kB
Ba-Ca to Ce-Cu/Comparing Variabilities in Clinical Research.pdf 696.9 kB
Da-Fa to Fo-In/ED50-ED90.pdf 692.7 kB
Qt-St to Su-Zs/Sample Size Determination.pdf 673.3 kB
Qt-St to Su-Zs/ROC Curve.pdf 670.0 kB
Da-Fa to Fo-In/Interactive Voice Randomization System (IVRS).pdf 665.2 kB
Qt-St to Su-Zs/Slope Approach for Assessment of Dose Proportionality-Linearity Under a Crossover Design.pdf 658.8 kB
No-Pr/Postmarketing Adverse Drug Event Signaling.pdf 633.7 kB
Da-Fa to Fo-In/In Vitro Micronucleus Test.pdf 621.3 kB
Da-Fa to Fo-In/Exploratory Factor Analysis.pdf 616.6 kB
Ka-Mu/Ministry of Health, Labour and Welfare and Pharmaceutical Administration in Japan.pdf 610.4 kB
Ka-Mu/Kaplan-Meier Estimator.pdf 603.9 kB
Qt-St to Su-Zs/Robust Analysis for Crossover Design.pdf 597.0 kB
Qt-St to Su-Zs/Toxicological Studies.pdf 591.9 kB
Ka-Mu/Meta-Analysis of Therapeutic Trials.pdf 591.6 kB
Ka-Mu/Lilly Reference Ranges.pdf 577.0 kB
Da-Fa to Fo-In/Interim Analysis.pdf 574.2 kB
No-Pr/Outlier Detection in Clinical Research.pdf 572.0 kB
Qt-St to Su-Zs/Spatio-Temporal Modeling.pdf 566.9 kB
Qt-St to Su-Zs/Survival Analysis.pdf 560.0 kB
No-Pr/P-Values.pdf 550.6 kB
No-Pr/Pharmacodynamics with Covariates.pdf 536.8 kB
Da-Fa to Fo-In/Integrated Summary Report.pdf 523.7 kB
Ba-Ca to Ce-Cu/Carcinogenicity Studies of Pharmaceuticals.pdf 518.1 kB
Da-Fa to Fo-In/Dose Proportionality.pdf 491.2 kB
Qt-St to Su-Zs/Reproducibility Probability in Clinical Research.pdf 486.0 kB
Ka-Mu/Medical Devices.pdf 479.4 kB
Da-Fa to Fo-In/Investigating Quality-of-Life in Clinical Trials.pdf 475.7 kB
Da-Fa to Fo-In/Data Mining and Biopharmaceutical Research.pdf 472.5 kB
Ka-Mu/Measuring Agreement.pdf 465.5 kB
No-Pr/P-Values, Evidence and Multiplicity Considerations for Controlled Clinical Trials.pdf 461.1 kB
Da-Fa to Fo-In/Instrument Development and Validation.pdf 446.0 kB
Ba-Ca to Ce-Cu/Biologics.pdf 438.3 kB
Ac-As/Acceptance Sampling.pdf 437.2 kB
Da-Fa to Fo-In/Data Monitoring Committees (DMC).pdf 435.8 kB
Ac-As/Assay Development.pdf 434.2 kB
Ac-As/Assay Validation.pdf 430.2 kB
Da-Fa to Fo-In/Group Sequential Methods.pdf 422.9 kB
Ac-As/Ames Test.pdf 415.8 kB
Qt-St to Su-Zs/Sample Size Calculation Based on Nonparametric Statistics.pdf 381.3 kB
No-Pr/Pharmacodynamics with No Covariates.pdf 380.2 kB
Da-Fa to Fo-In/Diagnostic Imaging.pdf 376.4 kB
Qt-St to Su-Zs/Subgroup Analysis.pdf 369.0 kB
Da-Fa to Fo-In/Genetic Linkage and Linkage Disequilibrium Analysis.pdf 361.7 kB
Ka-Mu/Maximum Tolerable Dose for Cancer Chemotherapy.pdf 358.9 kB
No-Pr/Pharmacodynamic Issues.pdf 357.1 kB
No-Pr/Proportional Hazards Regression Model.pdf 352.0 kB
Qt-St to Su-Zs/Reproductive-Developmental Studies.pdf 350.4 kB
Ba-Ca to Ce-Cu/Bayesian Statistics.pdf 345.9 kB
Ba-Ca to Ce-Cu/Calibration.pdf 345.0 kB
No-Pr/Phase I Cancer Clinical Trials.pdf 343.0 kB
Ka-Mu/Modified Large Sample Method.pdf 341.4 kB
Da-Fa to Fo-In/Individual Bioequivalence.pdf 341.1 kB
Ba-Ca to Ce-Cu/Cutoff Designs.pdf 337.9 kB
No-Pr/Postmarketing Surveillance.pdf 336.5 kB
Da-Fa to Fo-In/Dose Response Study Design.pdf 335.2 kB
Ba-Ca to Ce-Cu/Cancer Trials.pdf 332.0 kB
Ba-Ca to Ce-Cu/Crossover Design.pdf 331.2 kB
Da-Fa to Fo-In/Global Database and System.pdf 327.5 kB
Ka-Mu/Laboratory Analyses.pdf 321.3 kB
Da-Fa to Fo-In/False Discovery Rate (FDR).pdf 317.9 kB
Ka-Mu/Multinational Clinical Trial.pdf 316.4 kB
Da-Fa to Fo-In/Expiration Dating Period.pdf 312.0 kB
No-Pr/Population Bioequivalence.pdf 311.5 kB
Ac-As/Active Control Trials.pdf 311.0 kB
Da-Fa to Fo-In/Food and Drug Administration.pdf 310.2 kB
Da-Fa to Fo-In/Hypotheses and False Positive Rate in Active Control Non-Inferiority Trials.pdf 309.7 kB
Qt-St to Su-Zs/Sample Size Calculation for Survival Data.pdf 308.8 kB
Da-Fa to Fo-In/In Vitro Dissolution Profile Comparison.pdf 307.3 kB
Da-Fa to Fo-In/In Vitro Bioequivalence Testing.pdf 307.3 kB
Qt-St to Su-Zs/Validity of LOCF.pdf 306.0 kB
Da-Fa to Fo-In/Drug Development.pdf 302.1 kB
Qt-St to Su-Zs/Reliability.pdf 300.2 kB
No-Pr/Odds Ratio.pdf 300.2 kB
Ba-Ca to Ce-Cu/Confounding and Interaction.pdf 290.8 kB
Ac-As/Adverse Event Reporting.pdf 286.9 kB
Da-Fa to Fo-In/Good Clinical Practice.pdf 283.5 kB
Da-Fa to Fo-In/Good Programming Practice.pdf 281.9 kB
Ka-Mu/MedDRA and Its Impact on Pharmaceutical Development.pdf 278.6 kB
Ba-Ca to Ce-Cu/Blinding.pdf 278.0 kB
Qt-St to Su-Zs/Release Targets.pdf 274.0 kB
Ba-Ca to Ce-Cu/Bootstrap, The.pdf 271.4 kB
Ac-As/Analysis of Heritability.pdf 269.8 kB
Ba-Ca to Ce-Cu/Clustered Study Designs- Power Analysis.pdf 265.5 kB
Da-Fa to Fo-In/Imputation with Item Nonrespondents.pdf 263.9 kB
Ba-Ca to Ce-Cu/Bioavailability and Bioequivalence.pdf 261.2 kB
Qt-St to Su-Zs/Therapeutic Equivalence.pdf 258.5 kB
Ba-Ca to Ce-Cu/Carry-Forward Analysis.pdf 258.3 kB
Da-Fa to Fo-In/Equivalence Trials.pdf 257.3 kB
Da-Fa to Fo-In/Dropout.pdf 256.7 kB
Ba-Ca to Ce-Cu/Cost-Effectiveness Analysis.pdf 253.1 kB
Da-Fa to Fo-In/Dose Response Analysis in Clinical Trials.pdf 251.6 kB
No-Pr/Patient Compliance.pdf 251.6 kB
No-Pr/Population PK-PD Analysis.pdf 251.0 kB
Qt-St to Su-Zs/Selection of Control in Clinical Trials.pdf 249.3 kB
Qt-St to Su-Zs/Stability Matrix Designs.pdf 248.2 kB
Da-Fa to Fo-In/Good Statistics Practice.pdf 244.3 kB
Ka-Mu/Kullback-Leibler Divergence for Evaluating Equivalence.pdf 235.8 kB
Ba-Ca to Ce-Cu/Canadian Health Products and Food Branch (HPFB) and Therapeutic Products Directorate (TPD).pdf 233.2 kB
Qt-St to Su-Zs/Statistical Significance.pdf 227.8 kB
Qt-St to Su-Zs/Randomization.pdf 227.0 kB
Qt-St to Su-Zs/Rank Regression in Stability Analysis.pdf 224.2 kB
Ka-Mu/Mixed Effects Models.pdf 222.8 kB
Qt-St to Su-Zs/Stability Analysis for Frozen Drug Products.pdf 222.8 kB
No-Pr/Placebo Effect.pdf 221.3 kB
No-Pr/Parallel Design.pdf 220.9 kB
Qt-St to Su-Zs/Subject-Treatment Interaction.pdf 219.5 kB
Ba-Ca to Ce-Cu/Bridging Studies.pdf 218.8 kB
Qt-St to Su-Zs/Sample Size Re-estimation Based on Observed Treatment Difference.pdf 218.2 kB
No-Pr/Profile Analysis.pdf 217.6 kB
Ka-Mu/Minimization Procedure.pdf 215.5 kB
Ka-Mu/Minimum Effective Dose.pdf 215.5 kB
Qt-St to Su-Zs/Titration Design.pdf 215.4 kB
Ba-Ca to Ce-Cu/Contract Research Organization (CRO).pdf 209.9 kB
Qt-St to Su-Zs/Statistical Principles for Clinical Trials.pdf 207.8 kB
Ba-Ca to Ce-Cu/Case-Control Studies, Inference in.pdf 205.5 kB
Ba-Ca to Ce-Cu/Content Uniformity.pdf 203.4 kB
Qt-St to Su-Zs/SROC Curve.pdf 196.9 kB
Ba-Ca to Ce-Cu/Confidence Interval and Hypothesis Testing.pdf 192.0 kB
No-Pr/Prediction Trees.pdf 189.0 kB
Da-Fa to Fo-In/Ecologic Inference.pdf 184.3 kB
Da-Fa to Fo-In/Generalizability Probability in Clinical Research.pdf 183.0 kB
Da-Fa to Fo-In/Generalized Estimating Equation.pdf 183.0 kB
Da-Fa to Fo-In/Imputation in Clinical Research.pdf 181.7 kB
No-Pr/Percentile Charts on Correlated Measures.pdf 181.4 kB
No-Pr/Noninferiority Analysis in Active Controlled Clinical Trials.pdf 179.1 kB
Ba-Ca to Ce-Cu/Cluster Trials.pdf 177.3 kB
Ka-Mu/Multicenter Trials.pdf 176.2 kB
Da-Fa to Fo-In/Intention-to-Treat Analyses (ITT).pdf 175.9 kB
Qt-St to Su-Zs/QT Analysis.pdf 174.5 kB
Ac-As/Adjustment for Covariates.pdf 173.5 kB
No-Pr/Protocol Development.pdf 173.0 kB
Ba-Ca to Ce-Cu/Combination Drug Clinical Trial.pdf 173.0 kB
Ba-Ca to Ce-Cu/Clinical Endpoint.pdf 170.4 kB
Ba-Ca to Ce-Cu/Clinical Trial Process.pdf 169.0 kB
Qt-St to Su-Zs/Two-Stage Design- Phase II Cancer Clinical Trials.pdf 167.8 kB
Da-Fa to Fo-In/International Conference on Harmonization (ICH).pdf 165.6 kB
Ka-Mu/Latent Class Analysis.pdf 159.6 kB
Da-Fa to Fo-In/Failure-Time Model.pdf 159.1 kB
Ac-As/Adaptive Dose-Finding Based on Efficacy-Toxicity Trade-Offs .pdf 154.7 kB
Ba-Ca to Ce-Cu/Bayesian Two-Stage Design for Phase II Clinical Trials.pdf 154.3 kB
Ka-Mu/Multicollinearity.pdf 153.0 kB
Ka-Mu/Logistic Regression in Three-Point Designs.pdf 149.4 kB
Ba-Ca to Ce-Cu/Bioassay.pdf 149.0 kB
Ka-Mu/Coefficients in Medical Research.pdf 145.2 kB
No-Pr/Ordered Multiple Class Receiver Operating Characteristic (ROC) Analysis.pdf 142.5 kB
Da-Fa to Fo-In/Enrichment Design.pdf 141.4 kB
Qt-St to Su-Zs/Structural Equation Model.pdf 141.0 kB
Ac-As/Analysis of 2 K Tables .pdf 140.1 kB
Ba-Ca to Ce-Cu/Bioinformatics.pdf 136.8 kB
Da-Fa to Fo-In/Ethnic Factors.pdf 135.2 kB
Ba-Ca to Ce-Cu/Clinical Pharmacology.pdf 134.8 kB
Ka-Mu/Missing Values in Repeated Measurement Designs.pdf 130.8 kB
No-Pr/Principal Component Analysis.pdf 128.3 kB
Ba-Ca to Ce-Cu/Clinical Trial Simulations for Later Development Phases.pdf 126.5 kB
Ba-Ca to Ce-Cu/Clinical Trials.pdf 126.5 kB
Ac-As/Adaptive Designs.pdf 126.3 kB
No-Pr/Onset of Action.pdf 122.8 kB
Qt-St to Su-Zs/Statistical Tests for Biomarker Development with Applications to Genetics Data.pdf 121.9 kB
Ba-Ca to Ce-Cu/Center Weighting in Multicenter Trials.pdf 121.0 kB
Ba-Ca to Ce-Cu/Correlated Probit Model.pdf 118.6 kB
Qt-St to Su-Zs/Testing for Qualitative Interaction.pdf 113.7 kB
Ac-As/Alpha Spending Function.pdf 109.3 kB
Da-Fa to Fo-In/Group Sequential Tests and Variance Heterogeneity in Clinical Trials.pdf 109.2 kB
No-Pr/Power.pdf 106.3 kB
Ac-As/Analysis of Clustered Binary Data.pdf 104.8 kB
Ba-Ca to Ce-Cu/Clinical Trial Simulation.pdf 103.8 kB
Ac-As/Analysis of Repeated Measures Data with Missing Values- An Overview of Methods .pdf 102.2 kB
Ba-Ca to Ce-Cu/Bayesian Methods in Meta-Analysis.pdf 100.8 kB
Qt-St to Su-Zs/Trend Estimation.pdf 99.8 kB
Qt-St to Su-Zs/Specifications.pdf 99.3 kB
Da-Fa to Fo-In/Generalized Estimating Equations (GEE) Method- Sample Size Estimation.pdf 94.3 kB
Qt-St to Su-Zs/Risk Ratio Analysis.pdf 93.8 kB
Qt-St to Su-Zs/USP Tests.pdf 92.8 kB
Ba-Ca to Ce-Cu/Clinical Trial Simulations for Earlier Development Phases.pdf 90.7 kB
No-Pr/Proportion of Treatment Effect.pdf 89.2 kB
Qt-St to Su-Zs/Sequential Estimation for the Additive Hazards Rate Model with Staggered Entry.pdf 89.1 kB
Da-Fa to Fo-In/Factor Analysis.pdf 88.2 kB
Ka-Mu/McNemar's Test.pdf 87.1 kB
Qt-St to Su-Zs/Stuart-Maxwell Test.pdf 82.4 kB
Ka-Mu/Local Influence Analysis.pdf 78.1 kB
Ac-As/ANCOVA Approach for Premarketing Shelf Life Determination with Multiple Factors .pdf 74.1 kB
Qt-St to Su-Zs/Z-Score.pdf 70.7 kB
Ba-Ca to Ce-Cu/Bracketing Design.pdf 61.9 kB
Qt-St to Su-Zs/Screening Design.pdf 61.3 kB

==查看完整文档列表==

上一个：2020 Шкільні вінєтки10.6 GB
下一个：Fargo.S02.1080p.WEB-DL.MVO.LostFilm.Sub.Eng 24.2 GB

种子标签

Malestrom Statistics Ed 2nd Biopharmaceutical Encyclopedia

种子评价

优质的种子 (0) 假种子 (0) 有密码 (0) 低质量 (0) 有病毒 (0) 无法下载 (0)
欢迎对种子质量进行评价。

人气女优

北川ゆい Akira COCOLO Saiko あいだももあさのくるみあまいれもんいしかわ愛里いとうしいなうさみ恭香うちだまひろかぐやひめかとりこのみかないかほくすのき琴美クミコグレースくらもとまい（葉月ありさ）さとみ中村あみしいな純菜しのざきさとみ（三沢亜也）牧本千幸（つかもと友希）眞木ありさデヴィテラパトリックドミニカともさかまいともさか愛なごみもえひなこ

分享BT种子/磁力链接

亲，你知道吗？下载的人越多速度越快，赶快把本页面分享给好友一起下载吧^_^

2048BT

BT种子名称

Encyclopedia of Biopharmaceutical Statistics 2nd Ed. - (Malestrom)

分享给好友

BT种子基本信息

下载磁力链接

下载BT种子

文档列表

猜你喜欢

种子标签

种子评价

最近搜索

人气女优

最新番号

分享BT种子/磁力链接

友情链接